Sanjivani Paranteral Stock Plummets to New 52-Week Low at Rs. 193

Sanjivani Paranteral, a microcap player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by hitting a new 52-week low of Rs. 193 on October 24, 2025. This decline marks a notable underperformance, as the stock has trended downward for four consecutive days, resulting in a total drop of 3.68% during this period.
Today, the stock opened with a gap down of 6.83%, reflecting a challenging market environment. It has consistently traded below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a persistent bearish trend. Over the past year, Sanjivani Paranteral has seen a decline of 26.14%, contrasting sharply with the Sensex, which has gained 5.60% in the same timeframe.

Despite these challenges, the company has demonstrated high management efficiency, with a return on equity (ROE) of 21.72%. Additionally, net sales have grown at an annual rate of 32.53%, and operating profit has increased by 55.72%. Promoter confidence appears to be rising, as they have increased their stake in the company by 2.33% in the last quarter, now holding 31.2% of the company.